Possible reasons:
1. Make money.
2. Your main competitor has gone public and has raised a lot of money. It may only be a matter of time before it destroys you. If you continue to compete, both sides will be hurt and there is no chance of winning. At this time, being acquired by the other party may not be a bad choice.
3. The products and services you create are difficult to make money, but they have many users and have strategic value to some companies.
On June 13 last year, Jiuqiang Biotech announced that it would purchase 95.55 shares of Maixin Biotech in cash with Sinopharm Investment***, with a total transaction price of approximately 2.628 billion yuan. Among them, Jiuqiang Biotech will transfer a total of 65.55% of the equity of Maixin Biotech held by the counterparties, and Sinopharm Investment intends to transfer a total of 30% of the equity of Maixin Biotech held by the counterparties.
Extended information
Beijing Jiuqiang Biotechnology Co., Ltd. is a company whose main business is the research and development, production and sales of biochemical diagnostic reagents ("Kinsr" brand reagents) A high-growth enterprise with a series of products that are basically developing in step with the international market. The company is registered in Zhongguancun, Beijing, with a registered capital of RMB 500,828,609. It is a nationally recognized high-tech enterprise.
Won the title of 2006 China's Independent Innovation Enterprise;
Won the Forbes 2006 "China's Potential 100" enterprise;
2007
The homocysteine ??diagnostic kit product won the National Torch Program Project Certificate;
Won the Forbes 2007 "China's Potential 100" enterprise;
2008
p>Won the "Beijing Science and Technology Third Prize" issued by the Beijing Municipal People's Government;
Won a high-tech enterprise certificate;
Listed in Forbes for the third consecutive year Ranking list of China's most promising small and medium-sized enterprises";
2009 Cystatin C determination kit, homocysteine ??determination kit, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol detection kit Three products won the title of "Beijing Independent Innovation Products";
Won the "Beijing Private Science and Technology Industrialists Association Membership Certificate";
Two patents won the "Utility Model Patent Certificate" ;
For the fourth consecutive year, listed in the "Forbes Ranking of China's Most Potential Small and Medium-sized Enterprises";